BioSpace News Archive

Anixa Biosciences, Inc. today announced the initiation of a Phase 1b trial for its preventative breast cancer vaccine.

Surmodics Announces TRANSCEND Trial 24-Month Data to be Presented at VIVA 2022.

Jaguar Health, Inc. (NASDAQ:JAGX) and its wholly owned subsidiary Napo Pharmaceuticals today announced the publication in the peer reviewed journal Breast Cancer Research and Treatment of the results of the investigator-initiated HALT-D trial.

CohBar, Inc. announced that the company will release its 2022 third quarter financial results after the market closes on Tuesday, November 8, 2022.

Social and economic factors are causing couples to delay parenthood. It is generally accepted that maternal age is inversely related with fertility and pregnancy outcome.

PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ that has the potential to improve the absorption of many drugs currently on the market and to reduce the risk of stomach injury associated with certain drugs.

Precision Optics Corporation, Inc. announced that it will affect a 1-for-3 reverse split of its common stock in preparation for the planned listing of the common stock on The Nasdaq Stock Market.

ImpediMed Limited is pleased to announce publication of a systematic literature review showing that early detection and intervention of breast cancer-related lymphedema reduces rates of chronic lymphedema in breast cancer patients.

Virax Biolabs Group Limited announced today the initiation of its Virax Immune COVID-19 Analytical Performance Study scheduled to take place through Q4 of this year.

scPharmaceuticals Inc. (Nasdaq: SCPH) today announced that scPharmaceuticals’ management will host a conference call and audio webcast at 4:30 p.m. ET on Wednesday, November 9, 2022, to discuss third quarter financial results and provide a business update.